Evidence map›Paper›PMID 34905068›Full record

ArticleHistochemistry and cell biology2021

Alternative tissue fixation for combined histopathological and molecular analysis in a clinically representative setting.

Amelia Meecham, Elena Miranda, Hayley T Morris, Jane Hair, Karin A Oien, Gareth Gerrard, Naomi Guppy, David Mooney, Emily C Shaw, Margaret Ashton-Key and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. In focus in HCB.Histochemistry and cell biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Amelia MeechamResearch Department of Pathology, UCL Cancer Institute, London, UK.ORCID http://orcid.org/0000-0003-3067-7621
Elena MirandaResearch Department of Pathology, UCL Cancer Institute, London, UK.
Hayley T MorrisInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jane HairNHS Research Scotland Greater Glasgow and Clyde Biorepository, Glasgow, UK.
Karin A OienInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Gareth GerrardResearch Department of Pathology, UCL Cancer Institute, London, UK.
Naomi GuppyResearch Department of Pathology, UCL Cancer Institute, London, UK.
David MooneyDepartment of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
Emily C ShawDepartment of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Margaret Ashton-KeyDepartment of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Robert LeesDepartment of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Adrienne FlanaganResearch Department of Pathology, UCL Cancer Institute, London, UK.
Manuel Rodriguez-JustoResearch Department of Pathology, UCL Cancer Institute, London, UK. m.rodriguez-justo@ucl.ac.uk.
CRUK Lung Cancer Centre of Excellence · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Glasgow · GBNHS Research Scotland · GBQueen Elizabeth University Hospital · GBRoyal National Orthopaedic Hospital NHS Trust · GBUniversity College Hospital · GB

Funding

Innovate UK 38618-281179
6 · The paper itself

Abstract

Formalin is the principal tissue fixative used worldwide for clinical and research purposes. Despite optimal preservation of morphology, its preservation of DNA and RNA is poor. As clinical diagnostics increasingly incorporates molecular-based analysis, the requirement for maintaining nucleic acid quality is of increasing importance. Here we assess an alternative non-formalin-based tissue fixation method, PAXgene Tissue system, with the aim of better preserving nucleic acids, while maintaining the quality of the tissue to be used for vital existing diagnostic techniques. In this study, these criteria are assessed in a clinically representative setting. In total, 203 paired PAXgene Tissue and formalin-fixed samples were obtained. Blind-scored haematoxylin and eosin (H&E) sections showed comparable and acceptable staining. Immunohistochemistry (IHC) staining was suboptimal using existing protocols but improved with minor method adjustment and optimisation. Quality of DNA and RNA was significantly improved by PAXgene tissue fixation [RIN 2.8 versus 3.8 (p < 0.01), DIN 5.68 versus 6.77 (p < 0.001)], which translated into improved performance on qPCR assay. These results demonstrate the potential of PAXgene Tissue to be used routinely in place of formalin, maintaining adequate histological staining and significantly improving the preservation of biological molecules in the genomic era.

Indexed as

ImmunohistochemistryReal-Time Polymerase Chain ReactionTissue FixationDNAFormaldehydeHumansRNADNAFormaldehydeRNADNAFFPEFixativeFormalinPAXgeneRNA

Identifiers

PMID34905068
PMCPMC8695534
OpenAlexW4200573707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.